Percutaneous transhepatic cholangiography


Journal

World journal of gastroenterology
ISSN: 2219-2840
Titre abrégé: World J Gastroenterol
Pays: United States
ID NLM: 100883448

Informations de publication

Date de publication:
21 Jul 2022
Historique:
received: 22 11 2021
revised: 21 01 2022
accepted: 23 06 2022
entrez: 26 9 2022
pubmed: 27 9 2022
medline: 28 9 2022
Statut: ppublish

Résumé

Percutaneous transhepatic cholangiography is a diagnostic and therapeutic procedure that involves inserting a needle into the biliary tree, followed by the immediate insertion of a catheter. Endoscopic ultrasound-guided biliary drainage (EUS-BD) is a novel technique that allows BD by echoendoscopy and fluoroscopy using a stent from the biliary tree to the gastrointestinal tract. To compare the technical aspects and outcomes of percutaneous transhepatic BD (PTBD) and EUS-BD. Different databases, including PubMed, Embase, clinicaltrials.gov, the Cochrane library, Scopus, and Google Scholar, were searched according to the guidelines for Preferred Reporting Items for Systematic reviews and Meta-Analyses to obtain studies comparing PTBD and EUS-BD. Among the six studies that fulfilled the inclusion criteria, PTBD patients underwent significantly more reinterventions (4.9 The findings of this systematic review revealed that EUS-BD is linked with a higher rate of effective BD and a more manageable procedure-related adverse event profile than PTBD. These findings highlight the evidence for successful EUS-BD implementation.

Sections du résumé

BACKGROUND BACKGROUND
Percutaneous transhepatic cholangiography is a diagnostic and therapeutic procedure that involves inserting a needle into the biliary tree, followed by the immediate insertion of a catheter. Endoscopic ultrasound-guided biliary drainage (EUS-BD) is a novel technique that allows BD by echoendoscopy and fluoroscopy using a stent from the biliary tree to the gastrointestinal tract.
AIM OBJECTIVE
To compare the technical aspects and outcomes of percutaneous transhepatic BD (PTBD) and EUS-BD.
METHODS METHODS
Different databases, including PubMed, Embase, clinicaltrials.gov, the Cochrane library, Scopus, and Google Scholar, were searched according to the guidelines for Preferred Reporting Items for Systematic reviews and Meta-Analyses to obtain studies comparing PTBD and EUS-BD.
RESULTS RESULTS
Among the six studies that fulfilled the inclusion criteria, PTBD patients underwent significantly more reinterventions (4.9
CONCLUSION CONCLUSIONS
The findings of this systematic review revealed that EUS-BD is linked with a higher rate of effective BD and a more manageable procedure-related adverse event profile than PTBD. These findings highlight the evidence for successful EUS-BD implementation.

Identifiants

pubmed: 36158274
doi: 10.3748/wjg.v28.i27.3514
pmc: PMC9346459
doi:

Substances chimiques

Bilirubin RFM9X3LJ49

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3514-3523

Informations de copyright

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Références

Gastrointest Endosc. 2010 Dec;72(6):1175-84, 1184.e1-3
pubmed: 20970787
Endoscopy. 2003 Dec;35(12):1076-8
pubmed: 14648424
Endoscopy. 2001 Oct;33(10):898-900
pubmed: 11571690
World J Gastroenterol. 2008 Oct 21;14(39):6078-82
pubmed: 18932289
Cureus. 2018 Feb 26;10(2):e2228
pubmed: 29713573
World J Gastroenterol. 2013 Mar 7;19(9):1372-9
pubmed: 23538784
Radiology. 1991 Jun;179(3):703-7
pubmed: 2027978
J Clin Gastroenterol. 2012 Oct;46(9):768-74
pubmed: 22810111
Gastrointest Endosc. 2004 Jul;60(1):138-42
pubmed: 15229448
Saudi J Gastroenterol. 2018 Mar-Apr;24(2):115-121
pubmed: 29637919
Clin Endosc. 2020 Jan;53(1):82-89
pubmed: 31476843
Am J Surg. 1985 Aug;150(2):243-7
pubmed: 2411158
J Hepatobiliary Pancreat Sci. 2014 May;21(5):328-34
pubmed: 24026963
Gastrointest Endosc. 2017 Feb;85(2):357-364
pubmed: 27566055
Dig Dis Sci. 2015 Feb;60(2):557-65
pubmed: 25081224
Endosc Ultrasound. 2021 Sep-Oct;10(5):317-318
pubmed: 34677158
Lancet. 1994 Dec 17;344(8938):1655-60
pubmed: 7996958
Gastrointest Endosc. 2015 Dec;82(6):1110-5
pubmed: 26142558
World J Gastroenterol. 2012 Feb 14;18(6):491-7
pubmed: 22363114
J Clin Epidemiol. 2011 Apr;64(4):380-2
pubmed: 21185693
Cardiovasc Intervent Radiol. 2018 Oct;41(10):1566-1572
pubmed: 29872897
Gastrointest Endosc. 1996 Feb;43(2 Pt 1):102-6
pubmed: 8635700
Clin Exp Gastroenterol. 2017 Apr 03;10:67-74
pubmed: 28408850
Am J Med Sci. 1967 Sep;254(3):316-21
pubmed: 6054533
Clin Gastroenterol Hepatol. 2016 Jul;14(7):1011-1019.e3
pubmed: 26748220
J Clin Gastroenterol. 2015 Oct;49(9):764-70
pubmed: 25518004
Gastrointest Endosc. 2004 Jan;59(1):100-7
pubmed: 14722561
Best Pract Res Clin Gastroenterol. 2016 Oct;30(5):807-823
pubmed: 27931638
Gastrointest Endosc. 2016 Jan;83(1):160-5
pubmed: 26215648
Surg Endosc. 2016 Dec;30(12):5500-5505
pubmed: 27129552
Am J Gastroenterol. 2006 Sep;101(9):2031-7
pubmed: 16968509
PLoS Med. 2013;10(4):e1001419
pubmed: 23585737
United European Gastroenterol J. 2013 Aug;1(4):285-93
pubmed: 24917973
Endoscopy. 2006 Sep;38(9):935-9
pubmed: 16981114
Case Rep Gastroenterol. 2019 Sep 25;13(3):385-397
pubmed: 31616233
JOP. 2007 Jul 09;8(4):438-43
pubmed: 17625296
Gastrointest Endosc. 2014 Dec;80(6):1171
pubmed: 24830582
Pancreatology. 2011;11 Suppl 2:47-51
pubmed: 21464587
Eur J Radiol. 2009 Dec;72(3):412-7
pubmed: 18926655
Gastrointest Endosc. 2015 Apr;81(4):913-23
pubmed: 25484326

Auteurs

Zeinab Hassan (Z)

Internal Medicine, Stockport Hospitals NHS Foundation Trust, Manchester SK2 7JE, United Kingdom.

Eyad Gadour (E)

Department of Gastroenterology, University Hospitals of Morecambe Bay NHS Foundation Trust, Lancaster LA1 4RP, United Kingdom. eyadgadour@doctors.org.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH